Sudden death in young athletes: HCM or ARVC?

Cardiovascular Drugs and Therapy

Volumn 16, Issue 1, 2002, Pages 11-17

  Firoozi, Sam ^a   Sharma, Sanjay ^a   Hamid, M Shoaib ^a   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Athletes; Exercise; Hypertrophic cardiomyopathy; Sudden death

Indexed keywords

CONTRACTILE PROTEIN; MUTANT PROTEIN;

ADAPTATION; AGE; ALGORITHM; ATHLETE; CLINICAL EXAMINATION; CONFERENCE PAPER; FAMILY HISTORY; GENE MUTATION; HEART DEATH; HEART PALPITATION; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; SARCOMERE; SUDDEN DEATH; SYMPTOMATOLOGY; SYNCOPE; TRAINING;

ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; EXERCISE; HUMANS; INCIDENCE; MALE; SPORTS; UNITED STATES;

EID: 0036270274     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015307229339     Document Type: Conference Paper

References (67)

1. The association of changes in physical activity level and other lifestyle characteristics with mortality among men
2. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men
3. Physical activity and mortality in post-menopausal women
4. Leisure time physical activity and coronary artery disease. The US railroad study
5. Vigorous exercise in leisure-time: Protection against coronary heart disease
6. The incidence of primary cardiac arrest during vigorous exercise
7. Leisure-time physical activity levels and risk of coronary heart disease and death: The multiple risk intervention trial
8. Triggering of sudden death from cardiac causes by vigorous exertion
9. Sudden death in athletes: Lessons from the Hank Gathers affair
10. Sudden death in young athletes
11. Causes of death in competitive athletes
12. Sudden death in young competitive athletes: Clinicopathological correlations in 22 cases
13. Causes of sudden death in athletes
14. Sudden death and sport
15. Sudden cardiac death in sport
16. Non-traumatic sports death in high school and college athletes
17. Sudden death
18. Ventricular arrhythmias and sudden death in athletes
19. Right ventricular cardiomyopathy and sudden death in young people
20. Sudden death and the competitive athlete: Perspectives on preparticipation screening studies
21. Preventing sudden death
22. Sudden death in young competitive athletes. Clinical, demographic and pathological profiles
23. Report of the WHO/ESFC task force on the definition and classification of cardiomyopathies
24. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study
25. The current status of myocardial disarray in hypertrophic cardiomyopathy
26. Arrhythmia in hypertrophic cardiomyopathy. Influence on prognosis
27. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study
28. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, 2-dimensional echocardiographic study of 125 patients
29. The management of hypertrophic cardiomyopathy
30. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk
31. Prognosis of hypertrophic cardiomyopathy: Role of age and clinical electrocardiographic and haemodynamic features
32. Sports-related and non-sports related sudden cardiac death in young adults
33. The athletic heart syndrome
34. The upper limit of physiological hypertrophy in highly trained elite athletes
35. Cardiac disease in young trained athletes. Insights into methods for distinguishing athletes heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy
36. Considerations for racial differences in the athlete's heart
37. Electrocardiographic changes in 1000 highly trained junior elite athletes
38. 16th Bethesda Conference: Cardiovascular abnormalities in the athlete. Recommendations regarding eligibility for competition
39. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
40. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
41. Significance of abnormal ECGs in highly trained athletes
42. Physiological left ventricular hypertrophy
43. Non-invasive evaluation of ventricular hypertrophy in professional athletes
44. Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy
45. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy
46. Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning
47. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy
48. Familial form of arrhythmogenic right ventricular dysplasia
49. Familial occurrence of right ventricular dysplasia. A study involving nine families
50. Arrhythmogeni right ventricular dysplasia in a family
51. Identification of a deletion in plakaglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)
52. Right ventricular dysplasia. A report of 24 adult cases
53. Arrhythmogeni right ventricular dysplasia: Clinical features, diagnostic techniques and current management
54. Right ventricular cardiomyopathy and sudden death in young people
55. Right ventricular cardiomyopathy: Another cause of sudden death in the young
56. Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular tachycardia
57. Right, ventricular tachycardia: Clinical and electrocardiographic characteristics
58. Two dimensional echocardiography in arrhythmogenic right ventricular dysplasia
59. Right ventricular dysplasia: Angiographic study
60. Comparison of two dimensional echocardiographic and angiographic findings in arrhythmogenic right ventricular cardiomyopathy
61. ECG-gated magnetic resonance imaging in right ventricular dysplasia
62. Magnetic resonance imaging in right ventricular dysplasia
63. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome or no structural heart disease
64. Symmetric cardiac enlargement in highly trained endurance athletes: A two dimensional echocardiographic study
65. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease